BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 19808939)

  • 1. Human defensins and LL-37 in mucosal immunity.
    Doss M; White MR; Tecle T; Hartshorn KL
    J Leukoc Biol; 2010 Jan; 87(1):79-92. PubMed ID: 19808939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of defensins in gingiva and their role in periodontal health and disease.
    Chung WO; Dommisch H; Yin L; Dale BA
    Curr Pharm Des; 2007; 13(30):3073-83. PubMed ID: 17979750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defensins in the oral cavity: distribution and biological role.
    Gomes Pde S; Fernandes MH
    J Oral Pathol Med; 2010 Jan; 39(1):1-9. PubMed ID: 19895659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial antimicrobial peptides: review and significance for oral applications.
    Weinberg A; Krisanaprakornkit S; Dale BA
    Crit Rev Oral Biol Med; 1998; 9(4):399-414. PubMed ID: 9825219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial peptides: effectors of innate immunity in the skin.
    Barak O; Treat JR; James WD
    Adv Dermatol; 2005; 21():357-74. PubMed ID: 16350450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory properties of defensins and cathelicidins.
    Bowdish DM; Davidson DJ; Hancock RE
    Curr Top Microbiol Immunol; 2006; 306():27-66. PubMed ID: 16909917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of defensins and cathelicidin LL37 in auto-immune and auto-inflammatory diseases.
    Frasca L; Lande R
    Curr Pharm Biotechnol; 2012 Aug; 13(10):1882-97. PubMed ID: 22250708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.
    Komatsuzawa H; Ouhara K; Kawai T; Yamada S; Fujiwara T; Shiba H; Kurihara H; Taubman MA; Sugai M
    Curr Pharm Des; 2007; 13(30):3084-95. PubMed ID: 17979751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of epithelial beta-defensins and cathelicidins in host defense of the lung.
    Hiemstra PS
    Exp Lung Res; 2007 Dec; 33(10):537-42. PubMed ID: 18075828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host antimicrobial defence peptides in human disease.
    Agerberth B; Gudmundsson GH
    Curr Top Microbiol Immunol; 2006; 306():67-90. PubMed ID: 16909918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells.
    van Wetering S; Tjabringa GS; Hiemstra PS
    J Leukoc Biol; 2005 Apr; 77(4):444-50. PubMed ID: 15591123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial peptides: an essential component of the skin defensive barrier.
    Braff MH; Gallo RL
    Curr Top Microbiol Immunol; 2006; 306():91-110. PubMed ID: 16909919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defensins and mucosal protection.
    Mahida YR; Cunliffe RN
    Novartis Found Symp; 2004; 263():71-7; discussion 77-84, 211-8. PubMed ID: 15669635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human beta-defensins (-1, -2, -3, -4) and cathelicidin LL-37 induce IL-18 secretion through p38 and ERK MAPK activation in primary human keratinocytes.
    Niyonsaba F; Ushio H; Nagaoka I; Okumura K; Ogawa H
    J Immunol; 2005 Aug; 175(3):1776-84. PubMed ID: 16034119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cathelicidin and defensins in pulmonary inflammatory diseases.
    Herr C; Shaykhiev R; Bals R
    Expert Opin Biol Ther; 2007 Sep; 7(9):1449-61. PubMed ID: 17727333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review: Defensins and cathelicidins in lung immunity.
    Tecle T; Tripathi S; Hartshorn KL
    Innate Immun; 2010 Jun; 16(3):151-9. PubMed ID: 20418263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: an impaired barrier disease.
    Jäger S; Stange EF; Wehkamp J
    Langenbecks Arch Surg; 2013 Jan; 398(1):1-12. PubMed ID: 23160753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.
    Salzman NH; Underwood MA; Bevins CL
    Semin Immunol; 2007 Apr; 19(2):70-83. PubMed ID: 17485224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human beta-defensins in HIV infection.
    Weinberg A; Quiñones-Mateu ME; Lederman MM
    Adv Dent Res; 2006 Apr; 19(1):42-8. PubMed ID: 16672548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition.
    Levinson P; Kaul R; Kimani J; Ngugi E; Moses S; MacDonald KS; Broliden K; Hirbod T;
    AIDS; 2009 Jan; 23(3):309-17. PubMed ID: 19114868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.